MXPA03005676A - Formas de dosis solidas de sodio de divalproex. - Google Patents

Formas de dosis solidas de sodio de divalproex.

Info

Publication number
MXPA03005676A
MXPA03005676A MXPA03005676A MXPA03005676A MXPA03005676A MX PA03005676 A MXPA03005676 A MX PA03005676A MX PA03005676 A MXPA03005676 A MX PA03005676A MX PA03005676 A MXPA03005676 A MX PA03005676A MX PA03005676 A MXPA03005676 A MX PA03005676A
Authority
MX
Mexico
Prior art keywords
dosage forms
solid dosage
divalproex sodium
directed
divalproex
Prior art date
Application number
MXPA03005676A
Other languages
English (en)
Inventor
R Engh Kevin
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of MXPA03005676A publication Critical patent/MXPA03005676A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion se dirige a un proceso acuoso para granular compuestos de valproato, en el cual el pH de la solucion de granulacion se mantiene a un pH de 5 o abajo. La invencion tambien se dirige a formas de dosis en las cuales el contenido residual de solventes organicos se reduce a un nivel de 0.2% p/p o menos.
MXPA03005676A 2000-12-22 2001-11-27 Formas de dosis solidas de sodio de divalproex. MXPA03005676A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/748,659 US20020127277A1 (en) 2000-12-22 2000-12-22 Solid dosage forms of divalproex sodium
PCT/US2001/043158 WO2002051400A2 (en) 2000-12-22 2001-11-27 Solid dosage forms of divalproex sodium

Publications (1)

Publication Number Publication Date
MXPA03005676A true MXPA03005676A (es) 2004-04-21

Family

ID=25010383

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03005676A MXPA03005676A (es) 2000-12-22 2001-11-27 Formas de dosis solidas de sodio de divalproex.

Country Status (5)

Country Link
US (1) US20020127277A1 (es)
BR (1) BR0112281A (es)
CA (1) CA2431375A1 (es)
MX (1) MXPA03005676A (es)
WO (1) WO2002051400A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040005357A1 (en) * 2002-07-03 2004-01-08 Sherman Bernard Charles Extended-release tablets comprising divalproex sodium
WO2004071424A2 (en) * 2003-02-05 2004-08-26 Teva Pharmaceutical Industries, Ltd. Immediate release formulation of n-(2-propylpentanoyl)glycinamide
US20070048379A1 (en) * 2005-08-29 2007-03-01 Mintong Guo Valproate tablet
US10406105B2 (en) * 2007-06-06 2019-09-10 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
JP2010529073A (ja) * 2007-06-06 2010-08-26 ビーエーエスエフ ソシエタス・ヨーロピア チュアブル錠及びトローチ剤製造のための医薬製剤
CN101393181B (zh) * 2008-10-20 2012-04-25 陕西天森药物研究开发有限公司 双丙戊酸钠中有关物质的测定方法
CN111349003B (zh) * 2018-12-20 2023-10-03 四川科瑞德制药股份有限公司 一种丙戊酸钠的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ270438A (en) * 1995-02-02 1996-03-26 Bernard Charles Sherman Solid (granular) mixture of valproic acid (di-n-propyl acetic acid) and its sodium salt; pharmaceutical compositions
US6204255B1 (en) * 1997-03-11 2001-03-20 Hexal Ag Solid, non-deliquescent formulations of sodium valproate
AT408718B (de) * 1999-12-02 2002-02-25 Gerot Pharmazeutika Natriumvalproat-granulat mit verringerter hygroskopizität

Also Published As

Publication number Publication date
CA2431375A1 (en) 2002-07-04
US20020127277A1 (en) 2002-09-12
WO2002051400A2 (en) 2002-07-04
WO2002051400A3 (en) 2002-12-27
BR0112281A (pt) 2004-10-19

Similar Documents

Publication Publication Date Title
BR0107837A (pt) Processo para solubilização de compostos peptìdeo 1 semelhantes a glucagon
ATE237560T1 (de) Mit hydantoin verbesserte halogenwirksamkeit in zellstoff- und papier-anwendungen
IL94887A0 (en) Aqueous pharmaceutical suspension for substantially water insoluble pharmaceutical actives
EA200400259A1 (ru) Дезинфицирующий раствор на основе гипохлорита натрия и способ его получения
NO20021875D0 (no) Fremgangsmåte for stabilisering av benzimidazolforbindelser
MXPA02003916A (es) Composiciones antivirales para papel tisu.
MXPA03005676A (es) Formas de dosis solidas de sodio de divalproex.
ATE265846T1 (de) Butorphanol enthaltende formulierungen mit verzögerter freisetzung
BR0114251A (pt) Carbonato de sódio granulado obtido através de granulação por pulverização em leito fluido e um processo para sua produção
EA200401090A1 (ru) Композиция на основе диклофенака для местного лечения заболеваний орофарингеальной полости
AU2001250662A1 (en) Sequestering
SI1543826T1 (sl) Koncentrirana vodna raztopina ambroksola
BG106414A (en) Bioavailable dosage form of isotretinoin
MXPA03008837A (es) Una composicion farmaceutica estable de pravastatina.
BR0016210A (pt) Composição detergente em barra
IL152643A0 (en) Process for the purification of a salt of clavulanic acid
ES2064923T3 (es) Metodo para estabilizar una solucion acuosa acida de peroxido de hidrogeno que contiene cobre.
MXPA03005677A (es) Formas de dosis de sodio de divalproex y un proceso para su produccion.
BG103923A (en) Sulphate salt of hiv protease inhibitor with improved peroral absorption and biopresence
PT915818E (pt) Estabilizacao de perfluoroalquil-alquil-cetonas
FR2801046B1 (fr) Procede de traitement d'effluents aqueux contenant des composes peroxydes
BR0004879A (pt) Composições de borracha contendo um sal dissódico do ácido 3,3'-ditiodipropiÈnico
SV1989000049A (es) Procedimiento para obtencion de preparados efervencentes de ibuferon, ref. le a 26 462-sv